The Thoracic Oncology Group of Australasia (TOGA) is the leading lung cancer & mesothelioma clinical trials group in Australia & New Zealand.
Thoracic cancer poses a significant threat in Australia, surpassing the combined mortality rates of prostate and breast cancers. While significant progress has been made in research for the four most commonly diagnosed cancers, boasting a 90% chance of survival after 5 years, lung cancer lags behind with only an 18% chance of survival.
At TOGA, our primary focus is on conducting innovative research and advancing medical knowledge and practices. Through the delivery of cutting-edge clinical and translational research, we explore the latest treatments and strive to answer crucial clinical questions.
By improving outcomes for patients with thoracic cancers, TOGA not only provides essential hope and support to patients and their families but also integrates research findings to enhance routine healthcare treatments.
To eliminate thoracic cancers as a source of death, disability and suffering.
To prevent, treat and cure thoracic cancers through research, clinical trials, education and advocacy.
Courage
To pursue new challenges and novel solutions.
Integrity
To exemplify honesty and trustworthiness in all of our operations.
Equity
To bring an open mind free of prejudice to every interaction and to strive for equal opportunity.
Collaboration
Work with key stakeholders, organisations, and community groups who share our aim of defeating thoracic cancer.
Creativity & Innovation
Strive for and be open to unique and creative solutions.
Our strategic plan for 2022-2025 is centred around building capacity, collaborations and a sustainable organisation to help realise our mission.
Collaborations and partnerships of mutual benefit to contribute to TOGA’s long-term sustainability and excellence in thoracic cancer research and care.
Develop, resource and implement a comprehensive fundraising strategy and brand to attract new donors
An education program to translate best evidence into practice
Tailored concept development and funding application support to build capacity for multidisciplinary concept development, maximise funded concepts, and expand
trial program
A TOGA Board that possesses desired expertise to lead and develop TOGA with a succession strategy for positions that are critical to TOGA’s sustainability
The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.
PO Box 1103
Thornbury VIC 3071
Ph: +61 3 9087 3550
ABN: 47 641 984 198
Thoracic Oncology Group of Australasia is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity. Donations $2 and over are tax deductible.
Copyright © 2024 TOGA – Thoracic Oncology Group Australasia. No part of this site may be reproduced without our written permission.
